These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32853591)

  • 1. Ocular hypertension following 40 mg sub-Tenon triamcinolone versus 0.7 mg dexamethasone implant versus 2 mg intravitreal triamcinolone.
    Kuley B; Storey PP; Pancholy M; Bello N; Murphy J; Goodman J; Wibbelsman TD; Obeid A; Chiang A; Regillo C; Garg S
    Can J Ophthalmol; 2020 Dec; 55(6):480-485. PubMed ID: 32853591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular Hypertension Following Intravitreal Injection of 0.7mg Dexamethasone Implant versus 2mg Triamcinolone.
    Kuley B; Storey PP; Pancholy M; Obeid A; Murphy J; Goodman J; Wibbelsman TD; Regillo C; Chiang A
    Semin Ophthalmol; 2020 Feb; 35(2):141-146. PubMed ID: 32343619
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence, Risk Factors, Treatment, and Outcome of Ocular Hypertension following Intravitreal Steroid Injections: A Comparative Study.
    Badrinarayanan L; Rishi P; George R; Isaac N; Rishi E;
    Ophthalmologica; 2022; 245(5):431-438. PubMed ID: 35468616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide.
    Kuley B; Storey PP; Wibbelsman TD; Pancholy M; Zhang QE; Sharpe J; Bello N; Obeid A; Regillo C; Kaiser RS; Chiang A; Fineman MS; Vander JF; Gupta OP; Spirn MJ; Dunn JP; Mehta S; Park CH; Maguire JI; Garg S
    Curr Eye Res; 2021 Jun; 46(6):824-830. PubMed ID: 33522311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Ocular Complications after 0.7 mg Dexamethasone Implant versus 2 mg of Intravitreal Triamcinolone in Vitrectomized Eyes.
    Wakabayashi T; Liu CK; Anderson HE; Mahmoudzadeh R; Nguyen MK; Salabati M; Chiang A; Hsu J; Garg SJ; Spirn MJ
    Ophthalmol Retina; 2023 Jun; 7(6):480-488. PubMed ID: 36572383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OCULAR HYPERTENSION AFTER INTRAVITREAL INJECTION OF 2-MG TRIAMCINOLONE.
    Storey PP; Obeid A; Pancholy M; Goodman J; Borkar D; Su D; Regillo C
    Retina; 2020 Jan; 40(1):75-79. PubMed ID: 30308561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraocular pressure monitoring post intravitreal steroids: a systematic review.
    Kiddee W; Trope GE; Sheng L; Beltran-Agullo L; Smith M; Strungaru MH; Baath J; Buys YM
    Surv Ophthalmol; 2013; 58(4):291-310. PubMed ID: 23768920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure elevation after intravitreal or posterior sub-Tenon triamcinolone acetonide injection.
    Yamamoto Y; Komatsu T; Koura Y; Nishino K; Fukushima A; Ueno H
    Can J Ophthalmol; 2008 Feb; 43(1):42-7. PubMed ID: 18204501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pressure fluctuation following intravitreal dexamethasone implant and incidence of secondary ocular hypertension: a Zambian perspective.
    Raj P; Kumar K; Balasubramaniam S; Geetha CS; Agarwal A
    Pan Afr Med J; 2021; 39():108. PubMed ID: 34512844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of intravitreal triamcinolone and its impact on optic nerve morphology in patients treated for diabetic macular edema.
    Carreira AR; Marques N; Carreira P; Moraes F; Loureiro T; Telles Freitas P; Cardoso J; Campos N
    Eur J Ophthalmol; 2022 May; 32(3):1596-1601. PubMed ID: 34176301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and treatment approach of intraocular pressure elevation after various types of local steroids for retinal diseases.
    Wykrota AA; Abdin AD; Munteanu C; Löw U; Seitz B
    Graefes Arch Clin Exp Ophthalmol; 2023 Dec; 261(12):3569-3579. PubMed ID: 37432451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.
    Theodoropoulou S; Ellabban AA; Johnston RL; Cilliers H; Mohamed Q; Sallam AB
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):725-732. PubMed ID: 27878430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LONG-TERM INCIDENCE AND RISK FACTORS OF OCULAR HYPERTENSION FOLLOWING DEXAMETHASONE-IMPLANT INJECTIONS: THE SAFODEX-2 STUDY.
    Rezkallah A; Mathis T; Abukhashabah A; Voirin N; Malclès A; Agard É; Lereuil T; Denis P; Dot C; Kodjikian L
    Retina; 2021 Jul; 41(7):1438-1445. PubMed ID: 33315814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients.
    Choi W; Park SE; Kang HG; Byeon SH; Kim SS; Koh HJ; Lee S; Seong GJ; Kim CY; Kim M
    Br J Ophthalmol; 2019 Oct; 103(10):1380-1387. PubMed ID: 30523044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of intravitreal triamcinolone acetonide on intraocular pressure.
    Bakri SJ; Beer PM
    Ophthalmic Surg Lasers Imaging; 2003; 34(5):386-90. PubMed ID: 14509462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Bozkurt E; Kara N; Yazici AT; Yuksel K; Demirok A; Yilmaz OF; Demir S
    Am J Ophthalmol; 2011 Dec; 152(6):976-981.e2. PubMed ID: 21861972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Late steroid-induced ocular hypertension after intravitreal dexamethasone implants: A series of 20 cases].
    Billant J; Douma I; Agard E; Levron A; Bouvarel H; Leroux P; Badri Y; Dot C
    J Fr Ophtalmol; 2023 Nov; 46(9):1039-1046. PubMed ID: 37758545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma.
    Robin AL; Suan EP; Sjaarda RN; Callanan DG; Defaller J;
    Arch Ophthalmol; 2009 Feb; 127(2):173-8. PubMed ID: 19204235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
    Roth DB; Verma V; Realini T; Prenner JL; Feuer WJ; Fechtner RD
    Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the safety zone for steroid-induced ocular hypertension induced by intravitreal dexamethasone implantation.
    Choi W; Bae HW; Shin HJ; Kim EW; Kim CY; Kim M; Seong GJ
    Br J Ophthalmol; 2022 Aug; 106(8):1150-1156. PubMed ID: 33737305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.